51 - 75 of 7916 Results
Title
Year
- Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's Disease2024OPENTitle: Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's DiseaseJournal Name: Journal of Integrative NeurosciencePublisher: IMR PressVol: 23Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.31083/j.jin2309178Citation Count: 0
-
OPENTitle: CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PETJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-52298-2Citation Count: 0
-
OPENTitle: Activation of parkin by a molecular glueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41467-024-51889-3Citation Count: 0
- Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort2024OPENTitle: Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) CohortJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 14Issue #: 7Start Page: 1End Page: 14Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-240213Citation Count: 0
-
OPENTitle: An interpretable deep learning framework identifies proteomic drivers of Alzheimer’s diseaseJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2024.1379984Citation Count: 0
- Head-up Tilt Sleeping to Treat Orthostatic Intolerance in a Patient with Advanced Parkinson’s Disease: A Case Report2024OPENTitle: Head-up Tilt Sleeping to Treat Orthostatic Intolerance in a Patient with Advanced Parkinson’s Disease: A Case ReportJournal Name: Case Reports in NeurologyPublisher: S. Karger AGVol: 16Issue #: 1Start Page: 256End Page: 261Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1159/000541424Citation Count: 0
- How storage post sampling influences the stability of sebum when used for mass spectrometry metabolomics analysis?2024OPENTitle: How storage post sampling influences the stability of sebum when used for mass spectrometry metabolomics analysis?Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-71598-7Citation Count: 0
- NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations2024OPENTitle: NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29902Citation Count: 0
-
OPENTitle: A Novel MAG Variant Causes Hereditary Spastic Paraplegia in a Consanguineous Pakistani FamilyJournal Name: GenesPublisher: MDPI AGVol: 15Issue #: 9Start Page: 1203End Page: 1203Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3390/genes15091203Citation Count: 0
- Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W2024OPENTitle: Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275WJournal Name: CellsPublisher: MDPI AGVol: 13Issue #: 18Start Page: 1540End Page: 1540Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells13181540Citation Count: 0
- RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s disease2024OPENTitle: RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s diseaseJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 52Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkae776Citation Count: 0
-
OPENTitle: Understanding what aspects of Parkinson’s disease matter most to patients and familiesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-71555-4Citation Count: 0
- Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancer2024OPENTitle: Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancerJournal Name: Nature MetabolismPublisher: Springer Science and Business Media LLCVol: 6Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42255-024-01118-4Citation Count: 0
- SVA Regulation of Transposable Element Clustered Transcription within the Major Histocompatibility Complex Genomic Class II Region of the Parkinson’s Progression Markers Initiative2024OPENTitle: SVA Regulation of Transposable Element Clustered Transcription within the Major Histocompatibility Complex Genomic Class II Region of the Parkinson’s Progression Markers InitiativeJournal Name: GenesPublisher: MDPI AGVol: 15Issue #: 9Start Page: 1185End Page: 1185Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes15091185Citation Count: 0
- A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s disease2024OPENTitle: A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s diseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2024.1431549Citation Count: 0
- Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials2024OPENTitle: Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII TrialsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 14Issue #: 6Start Page: 1243End Page: 1255Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-240035Citation Count: 0
- Cohort-specific Boolean models highlight different regulatory modules during Parkinson’s disease progression2024OPENTitle: Cohort-specific Boolean models highlight different regulatory modules during Parkinson’s disease progressionJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 10Start Page: 110956End Page: 110956Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2024.110956Citation Count: 0
- Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse models2024OPENTitle: Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse modelsJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 102251End Page: 102251Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2024.102251Citation Count: 1
-
OPENTitle: SynBot is an open-source image analysis software for automated quantification of synapsesJournal Name: Cell Reports MethodsPublisher: Elsevier BVVol: 4Issue #: 9Start Page: 100861End Page: 100861Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100861Citation Count: 0
-
RESTRICTEDTitle: Validating New Symptom Emergence as a Patient-Centric Outcome Measure for PD Clinical TrialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107118End Page: 107118Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107118Citation Count: 0
-
OPENTitle: An Inducible Luminescent System to Explore Parkinson’s Disease-Associated GenesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 17Start Page: 9493End Page: 9493Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25179493Citation Count: 0
- Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populations2024OPENTitle: Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populationsJournal Name: Alzheimer's & DementiaPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14208Citation Count: 1
-
RESTRICTEDTitle: Inflammation and heterogeneity in synucleinopathiesJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3389/fimmu.2024.1432342Citation Count: 0
- Shared and distinct cortical morphometric alterations in five neuropsychiatric symptoms of Parkinson’s disease2024OPENTitle: Shared and distinct cortical morphometric alterations in five neuropsychiatric symptoms of Parkinson’s diseaseJournal Name: Translational PsychiatryPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41398-024-03070-zCitation Count: 0
- Medication improves velocity, reaction time, and movement time but not amplitude or error during memory‐guided reaching in Parkinson's disease2024OPENTitle: Medication improves velocity, reaction time, and movement time but not amplitude or error during memory‐guided reaching in Parkinson's diseaseJournal Name: Physiological ReportsPublisher: WileyVol: 12Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14814/phy2.16150Citation Count: 0